USU gains French grid operator as a customer for software license management
Möglingen, October 19, 2022. USU, the leading provider in the area of software asset management…
Year: 2022
BioVie’s Phase 2 Trial Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease is Fully Enrolled
Topline Data Expected December 2022 CARSON CITY, Nev., Oct. 19, 2022 (GLOBE NEWSWIRE) — BioVie…
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Expanded partnership covers biosimilar candidates in immunology and oncology REYKJAVIK, Iceland and BOUCHERVILLE, Quebec, Oct….
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options for Patients in Specialty Care
Expanded partnership covers biosimilar candidates in immunology and oncology Alvotech (NASDAQ: ALVO), a global biotech…
Innovative New Product Platform from AppTech Payments Corp. Will Transform Fintech Industry
A fresh approach to conducting commerce between businesses and consumers CARLSBAD, Calif., Oct. 19, 2022…
Ideal Homes Portugal Introduces Their Services to American Property Investors
Ideal Homes Portugal, a real estate company in the Algarve, is helping American citizens Lagos,…
LBank Exchange Will List Spectre Chain (SPC) on October 20, 2022
Internet City, Dubai–(Newsfile Corp. – October 19, 2022) – LBank Exchange, a global digital asset…
Tsquared Personal Training Announces Lower Back Fitness Classes In Vancouver
Tsquared Personal Training (+1-604-250-9784) has announced a new program to assist clients with back pain….
CITIC Telecom CPC wins Best in Future of Operations at IDC Future Enterprise Awards 2022
HONG KONG, Oct 19, 2022 – (ACN Newswire) – CITIC Telecom International CPC Limited (CITIC…
Excelpoint and Bkav Signs Strategic Collaboration to Develop and Commercialise AIoT Platform based on Qualcomm Technology Ecosystem
Nasdaq-listed technology innovator, Qualcomm, will form a tripartite alliance with Bkav and Excelpoint to create…
Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2022
NEW YORK–(BUSINESS WIRE)–Ares Commercial Real Estate Corporation (NYSE: ACRE) announced today that it will report…
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
PALO ALTO, Calif.–(BUSINESS WIRE)–Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and…
U.S. Data Center Construction Market Report 2022: Big Data & IoT Driving Sector Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “U.S. Data Center Construction Market – Industry Outlook & Forecast 2022-2027” report has…
MUFG Announces December 1 Closing Date of the Sale of MUFG Union Bank to U.S. Bancorp
TOKYO & NEW YORK–(BUSINESS WIRE)–On September 21, 2021, MUFG and MUFG Bank, a core banking…
Industry Report Reveals 33% Plan to Deploy Wi-Fi 7 by 2024
WBA cross-industry survey reveals Wi-Fi 7 is top global priority to supercharge Wi-Fi capabilities and…
Rosslyn Named in Spend Matters 50 Providers to Know for Third Consecutive Year
The Procurement Analytics Leader Continues its Unbroken String of Analyst Recognition for its solid expertise…
Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines
Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of…
Nicox Provides Third Quarter 2022 Financial and Business Highlights
Press Release Nicox Provides Third Quarter 2022 Financial and Business Highlights Topline results of the…
Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumors
Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumors…
Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022
OCREVUS data will show significant benefit on slowing disease activity and progression in patients with…